Drug testing & safety: what's the connection?
Reilly, J.
Occupational Health and Safety 83(9): 80 82
2014
ISSN/ISBN: 0362-4064 PMID: 25272924 Document Number: 675811
Document emailed within 1 workday
Related Documents
Lemburg, P. 1988: Recommendation for technical safety testing limited to operating safety and functional capacity of respirators Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 136(1): 51-52Dernocoeur, K.; Meade, D.M. 1998: Safety and the field/dispatch connection Emergency Medical Services 27(8): 23-24
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Cone, E.J. 2006: Oral fluid testing: new technology enables drug testing without embarrassment Journal of the California Dental Association 34(4): 311-315
Mitarai, S. 2005: The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories Kekkaku: 80(4): 349-358
Danielsson, S. 2002: Is there a risk of revision in connection with the drug reform? Lakartidningen 99(20): 2332
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Purandare, B. 2015: Successful Management of Highly Drug-Resistant Tuberculosis with Individualized Drug Susceptibility Testing Journal of the Association of Physicians of India 63(7): 94-95
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261
Berg, R.M.G.; Møller, K.; Rossel, P.J.H. 2011: How to protect acutely ill, unconscious patients in connection with drug trials? Ugeskrift for Laeger 173(12): 919
Leonard, B. 1987: Drug safety and drug toxicity: the Irish situation Irish Medical Journal 80(4): 106-107
Landau, J.F.; Durand, M.; Vincent, P.; Guilmet, D.; Delamare, J. 1983: Hypoplasia of the right ventricle and cyanosis due to left-right atrial shunt within the framework of Turner's syndrome. Surgical closing of the interatrial connection after occlusion testing with balloon catheterization Archives des Maladies du Coeur et des Vaisseaux 76(2): 233-237
Vannier, P. 1992: Presentation of the directive 81/852/EEC (92/18) safety testing Developments in Biological Standardization 79: 47-50
Stark, D.M.; Puryear, S.K.; Ford, P.R. 1997: Safety testing--an essential use of laboratory animals Contemporary Topics in Laboratory Animal Science 36(5): 40-41
Lu, J.-m.; Wang, J.; Huang, X.-c.; Hu, Z.-y.; Cui, Z.-l. 2011: Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum Zhonghua Yu Fang Yi Xue Za Zhi 45(1): 21-25
Berge, J.A.; Gramstad, L.; Bodd, E. 1991: Safety testing the Bain circuit--a new test adaptor European Journal of Anaesthesiology 8(4): 309-310
Sun, D.; Yu, L.X.; Hussain, M.A.; Wall, D.A.; Smith, R.L.; Amidon, G.L. 2004: In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome Current Opinion in Drug Discovery and Development 7(1): 75-85
Kimbel, K.H. 1978: Drug safety through drug legislation Der Internist 19(6): 326-332
Sjöqvist, F. 2001: More stringent requirements in connection with the choice of drugs. Members of the drug committees in Stockholm deliver an annual declaration of challengeability Lakartidningen 98(6): 541-543